Topic: Cerus Corporation

Cerus Co. (CERS) Posts Large Volume Increase, 810,000 Shares Trade Hands.

American Banking News - 68 days ago
810,191 shares of Cerus Co. (CERS) traded hands on Tuesday, a 85.26% increase in volume compared to its 20-day average. The stock last traded at...

Cerus Co. (CERS) Posts Large Volume Increase, 724,000 Shares Trade Hands.

American Banking News - 86 days ago
723,999 shares of Cerus Co. (CERS) traded hands on Friday, a 36.01% increase in volume compared to its 20-day average. The stock last traded at...

Cerus (CERS) Share Price Target Raised to $5.00 by MLV & Co Analysts

American Banking News - 94 days ago
Equities research analysts at MLV Co raised their price target on shares of Cerus (NASDAQ: CERS) from $4.00 to $5.00 in a research issued note to...

Cerus Co. (CERS) Hits New 52-Week Low at $2.09

American Banking News - 188 days ago
Shares of Cerus Co. (CERS) hit a new 52-week low on Monday. The stock traded as low as $2.09 during mid-day trading and last traded at $2.10. The...

Hires and promotions, June 6

San Francisco Chronicle - 250 days ago
Kilpatrick Townsend & Stockton has named Bill Shaffer the new managing partner of the firm's Palo Alto office. He is a member of the firm's ...

Wedbush Analysts Begin Coverage on Cerus Co. (CERS)

American Banking News - 251 days ago
Equities research analysts at Wedbush initiated coverage on shares of Cerus Co. (NASDAQ: CERS) in a research note to investors on Friday. The...

Cerus Appoints William Greenman as President and CEO

Benzinga.com - 298 days ago
Posted on 04/20/11 at 8:36am by Benzinga Staff . The Board of Directors of Cerus Corporation (NASDAQ: CERS ) announced today that William “Obi”...

Low-Priced Biotech Stocks With Insider Buying

SeekingAlpha - 331 days ago
The biotechnology companies below recently have reported insider buying. I watch for companies that are seeing insider buying to help me find...

RW Baird Downgrades CERS To Neutral

Benzinga.com - 345 days ago
Posted on 03/04/11 at 6:33am by Lisa Levin . Analysts at RW Baird downgrade Cerus Corporation (NASDAQ: CERS ) from “outperform” to “neutral.” The...

Cerus' INTERCEPT Platelet System Succeeds in 3-Year French Study

Drugs.com - 503 days ago
CERS) announced today the favorable outcome of a large French study evaluating transfusion of over 13,000 platelet components treated with the INTERCEPT Blood System. The study was performed by the Etablissement Fran?ais du Sang (EFS) of Alsace, France, which is ...